Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 19. November 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16919  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 338377  
   
Occult Malignancy and Atypical Proliferative Lesions in Reduction Mammaplasty Specimens Without History of Breast Cancer: Systematic Review and Meta-Analysis.
Aesthet Surg J
Skorochod R, Gronovich Y.
PMID: 43055120 [PubMed - as supplied by publisher]


Early Detection of Ovarian Cancer: Current Strategies and Future Directions.
Expert Rev Mol Med
Zhang N, Zhuang D, Wang Y, Guo C, Gao Y, Feng Y, Wu H, Zhang Y, Hu G.
PMID: 43055119 [PubMed - indexed for MEDLINE]


Immunohistochemical Insights on Mismatch Repair Proteins in Ovarian Carcinoma: A North Indian Cohort Study.
J Midlife Health
Chawhan P, Sharma S, Singh M.
PMID: 43054996 [PubMed]


Cancer Risk in Premature Ovarian Insufficiency: Current Evidence and Clinical Implications.
J Midlife Health
Devanbu VGC, John JB, Karpagam KV.
PMID: 43054964 [PubMed]


Familial germ cell tumors: A case of ovarian yolk sac tumor in a patient with Lynch syndrome and two brothers diagnosed with testicular seminomas.
Gynecol Oncol Rep
Crockett SA, Singleton M, O'Daniel J, Ferrick JP, Clark LH.
PMID: 43054867 [PubMed]


AI-driven Immuno-Radio-Multi-Omics in triple-negative breast cancer: mapping the immune landscape for precision immunotherapy.
Front Immunol
Haloum I, Badou A.
PMID: 43054707 [PubMed - indexed for MEDLINE]


Development, Comparison With Genetic Counselors' Assessments, and Usability Evaluation of Japanese Version of Cancer Risk Assessment System in Primary Care (JCRAS-PC) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
J Gen Fam Med
Narumoto K, Kojima R, Shibata A, Miyazaki K, Koizumi K, Osawa H, Kato S, Iwaizumi M.
PMID: 43054666 [PubMed]


Multimodal versus Conventional Opioid-Based Analgesia and Postoperative Outcomes After Breast Cancer Surgery: A Retrospective Cohort Study.
J Pain Res
Guo H, Liu X, Meng Y, Li M, Niu Y.
PMID: 43054601 [PubMed]


MicroRNA-mediated crosstalk between Wnt/β-catenin signaling and the NLRP3 inflammasome in breast cancer: mechanistic evidence and therapeutic implications.
Front Oncol
Bharti M, Mishra S, Khanna S, Kailashiya J, Mishra SP.
PMID: 43054551 [PubMed]


Reciprocal Risk of Cutaneous Melanoma and Female Breast Carcinoma: A Queensland Population Study, 1995-2022.
Int J Breast Cancer
Jeyakumar A, Ng SK, Lam AK, Gopalan V.
PMID: 43054545 [PubMed]


Rewiring the breast cancer immune microenvironment through non-coding RNA-macrophage crosstalk: therapeutic vulnerabilities for immune reprogramming.
Front Immunol
Kumar S, Sharma P, Nema RK, Sisodiya S, Pramanik R, Hussain S, Singh S.
PMID: 43054268 [PubMed - indexed for MEDLINE]


Rewiring immune cell death in ovarian cancer: pyroptosis, apoptosis, and the immunosuppressive microenvironment.
Front Cell Dev Biol
Zhu H, Kang L, Shen L.
PMID: 43054258 [PubMed]


Pharmacokinetic and dosimetric evaluation of [(177)Lu]Lu-FAPI for stromal-targeted radionuclide therapy in triple-negative breast cancer: a preclinical biodistribution and dosimetry study.
Front Oncol
Tang Z, Yu L, Zhang K.
PMID: 43054127 [PubMed]


A body shape index and body roundness index in women with and without the polyendocrine metabolic ovarian syndrome: a systematic review and meta-analysis.
Gynecol Endocrinol
Pérez-López FR, Fernández-Alonso AM, Hernández-Bustamante EA, Vergara-Peña JM, Ulloque-Badaracco JR, Benites-Zapata VA.
PMID: 43053467 [PubMed - indexed for MEDLINE]


Association between HER2 expression levels and sonographic features in triple-negative breast cancer.
Cancer Imaging
Wang D, Zheng L, Zhu C, Jin D, Zheng X, Xu J.
PMID: 43053257 [PubMed - indexed for MEDLINE]


Tumor-draining lymph nodes as candidate sources of immunotherapy biomarkers in breast cancer: a multi-omics and artificial intelligence roadmap.
Biomark Res
Li Z, Pei S, Qu Z, Zhang L, Lu J, Xian K, Wang J, Fang Y.
PMID: 43053248 [PubMed]


Evaluation of lesion and neoadjuvant treatment response using low-keV dual-energy CT in breast cancer.
Cancer Imaging
Wang Z, Luo Y, You L, Cao K, Long R, Li XT, Sun YS.
PMID: 43053240 [PubMed - indexed for MEDLINE]


Beyond a one-size-fits-all prescription: shared and differential anti-inflammatory responses to exercise modalities in polycystic ovary syndrome.
J Ovarian Res
Wang J, Li J, Li C, Zou X.
PMID: 43053185 [PubMed - indexed for MEDLINE]


Antibody-drug conjugates in HR-positive, HER2-negative metastatic breast cancer: evolving clinical roles and translational directions.
J Hematol Oncol
Lin S, Zeng C, Liu X, Bao X, Wang J, Ma F.
PMID: 43053184 [PubMed - indexed for MEDLINE]


Innovative pathomics approach: integrating radiomic and CNN features for breast cancer classification using histopathological images.
Diagn Pathol
Alsallal M, Habeeb MS, Shareef A, Jyothi SR, Nayak PP, Chauhan AS, Singla S, Sameer HN, Yaseen A, Athab ZH, Adil M, Farhood B.
PMID: 43053106 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 338377    Seite 1 von 16919  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1